Brain imaging technique could help identify those who will develop Alzheimer's

Researchers have discovered a way to predict whether someone with cognitive decline will develop Alzheimer's disease: They measure the size of certain areas of that person's brain, according to a new report.

An automated process called Volumetric MRI measures the brain's memory centers, the report from the University of California, San Diego, found. Those brain areas, which include the hippocampus, amygdala and temporal horn, are then compared to their "expected size." According to researchers, patients with mild cognitive impairment that experience atrophy in those areas of the brain are much more likely to progress to Alzheimer's disease. Mild cognitive impairment (MCI) is considered a transitional stage between the forgetfulness associated with normal aging and Alzheimer's disease.

The fully automated process provides an objective observation of three areas of the brain. This is more effective than traditional, subjective physician interpretation of regular MRIs, which tend to focus solely on the hippocampus. The technique can be readily used in clinics, according to the report, which appears in the June issue of the journal Alzheimer's Disease and Associated Disorders,.

More in News

Government agency launches health IT webpage for long-term care providers

Government agency launches health IT webpage for long-term ...

The Office of the National Coordinator for Health Information Technology has unveiled a new webpage with information and resources for long-term and post-acute (LTPAC) providers.

FDA responds to provider pressure, backs off stricter control of fecal transplants ...

Individuals with treatment-resistant Clostridium difficile can undergo fecal transplants after giving informed consent, the Food and Drug Administration recently announced. This is a victory for providers, who pushed back after the FDA recently announced it would tighten regulations around the transplants.

Judge denies Omnicare's 'untimely' motion to disqualify whistleblower in nursing home kickbacks ...

Omnicare has failed to disqualify a whistleblower who alleges the long-term care pharmacy paid kickbacks to nursing homes, ruled a district court judge.